MedPath

RIBAVIRIN

Ribavirin for Inhalation Solution, USP Rx Only

Approved
Approval ID

2c3a64d5-fde2-437b-bafc-e76dd187d85a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 2, 2022

Manufacturers
FDA

Zydus Pharmaceuticals USA Inc.

DUNS: 156861945

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ribavirin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68382-395
Application NumberANDA207366
Product Classification
M
Marketing Category
C73584
G
Generic Name
ribavirin
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 2, 2022
FDA Product Classification

INGREDIENTS (1)

RIBAVIRINActive
Quantity: 6 g in 1 1
Code: 49717AWG6K
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIBAVIRIN - FDA Drug Approval Details